The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131

Peer Review reports

Original Submission
13 Jul 2012	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
8 Aug 2012	Reviewed	Reviewer Report - Dongmei He
9 Nov 2012	Reviewed	Reviewer Report - Catherine Brenner
3 Dec 2012	Author responded	Author comments - Yong Hyun Jeon
Resubmission - Version 3
3 Dec 2012	Submitted	Manuscript version 3
7 Dec 2012	Reviewed	Reviewer Report - Dongmei He
2 Jan 2013	Author responded	Author comments - Yong Hyun Jeon
Resubmission - Version 4
2 Jan 2013	Submitted	Manuscript version 4
2 Jan 2013	Author responded	Author comments - Yong Hyun Jeon
Resubmission - Version 5
2 Jan 2013	Submitted	Manuscript version 5
6 Jan 2013	Reviewed	Reviewer Report - Dongmei He
15 Jan 2013	Author responded	Author comments - Yong Hyun Jeon
Resubmission - Version 6
15 Jan 2013	Submitted	Manuscript version 6
Publishing
30 Jan 2013	Editorially accepted
22 Mar 2013	Article published	10.1186/1471-2407-13-143

Back to article page